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a b s t r a c t
Seafood is a highly traded food commodity. Farmed and captured crustaceans contribute a signiﬁcant
proportion with annual production exceeding 10 M metric tonnes with ﬁrst sale value of $40bn. The sector is dominated by farmed tropical marine shrimp, the fastest growing sector of the global aquaculture
industry. It is signiﬁcant in supporting rural livelihoods and alleviating poverty in producing nations
within Asia and Latin America while forming an increasing contribution to aquatic food supply in more
developed countries. Nations with marine borders often also support important marine ﬁsheries for crustaceans that are regionally traded as live animals and commodity products. A general separation of net
producing and net consuming nations for crustacean seafood has created a truly globalised food industry.
Projections for increasing global demand for seafood in the face of level or declining ﬁsheries requires
continued expansion and intensiﬁcation of aquaculture while ensuring best utilisation of captured stocks.
Furthermore, continued pressure from consuming nations to ensure safe products for human consumption are being augmented by additional legislative requirements for animals (and their products) to be of
low disease status. As a consequence, increasing emphasis is being placed on enforcement of regulations
and better governance of the sector; currently this is a challenge in light of a fragmented industry and less
stringent regulations associated with animal disease within producer nations. Current estimates predict
that up to 40% of tropical shrimp production (>$3bn) is lost annually, mainly due to viral pathogens for
which standard preventative measures (e.g. such as vaccination) are not feasible. In light of this problem,
new approaches are urgently required to enhance yield by improving broodstock and larval sourcing,
promoting best management practices by farmer outreach and supporting cutting-edge research that
aims to harness the natural abilities of invertebrates to mitigate assault from pathogens (e.g. the use
of RNA interference therapeutics). In terms of ﬁsheries losses associated with disease, key issues are centred on mortality and quality degradation in the post-capture phase, largely due to poor grading and handling by ﬁshers and the industry chain. Occurrence of disease in wild crustaceans is also widely reported,
with some indications that climatic changes may be increasing susceptibility to important pathogens (e.g.
the parasite Hematodinium). However, despite improvements in ﬁeld and laboratory diagnostics, deﬁning
population-level effects of disease in these ﬁsheries remains elusive. Coordination of disease specialists
with ﬁsheries scientists will be required to understand current and future impacts of existing and emergent diseases on wild stocks. Overall, the increasing demand for crustacean seafood in light of these
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issues signals a clear warning for the future sustainability of this global industry. The linking together of
global experts in the culture, capture and trading of crustaceans with pathologists, epidemiologists, ecologists, therapeutics specialists and policy makers in the ﬁeld of food security will allow these issues to be
better identiﬁed and addressed.
Crown Copyright Ó 2012 Published by Elsevier Inc. All rights reserved.
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1. Food security and globalisation in context
Global population projections predict expansion of the human
population from the current estimate of 7bn to between 8.8 and
9.1bn by 2050 (Fischer et al., 2009; Anderson, 2010). However,
the proportional change in different global regions is not equal,
with projections for so-called High-Income Countries (HICs) such
as the USA and countries of Europe remaining almost static against
signiﬁcant proportional increases in South and East Asia, the Middle East, North Africa and sub-Saharan Africa (Fischer et al., 2009;
Anderson, 2010). In the context of food consumption, it is clear that
not only will this increase require signiﬁcantly elevated overall
food production but changes in consumption patterns (e.g. the
shift from grains and other staples towards livestock) will accompany the expanding middle-income sector within these growing
populations (Anderson, 2010).
In the three decades between 1970 and 2000, signiﬁcant increases in global food consumption per capita have occurred, rising
by almost 400 kcal per person per day over the period. This has resulted in reductions in under-nutrition and food poverty globally,
though this trend has not been observed in some regions (e.g.
sub-Saharan Africa) (Kearney, 2010). Interestingly, not only has
calorie consumption changed but diet composition has also shifted
in several regions; for example in China, the increased available
consumption of vegetable oils (680%), meat (349%) and sugar
(305%) has accompanied a decline in consumption of pulses, roots
and tubers over the period 1963–2003 (Kearney, 2010). It is noted
that these large scale shifts in consumption pattern occur in two
distinct phases, the ﬁrst involving an ‘expansion’ in calorie intake
(i.e. from cheaper food stuffs of vegetable origin), and the second
involving ‘substitution’ of these carbohydrate-rich staples with
vegetable oils, animal products (meat and dairy foods) and sugar
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(Kearney, 2010). It is generally accepted that economic development of a nation is accompanied by a ‘westernisation’ of the diet,
epitomised by increased intake of meats, fats, processed foods, sugar and salt (Kearney, 2010). This so-called ‘nutritional transition’
has the effect of replacing population-level malnourishment with
nutrition related non-communicable diseases (NR-NCDs) such as
obesity and diabetes which predominate where increased consumption of unhealthy foods occurs (Popkin, 1999).
Increased food consumption has several diverse driving forces.
Changes in income (global per capita income is projected to rise
by at least 2 per cent per annum in the next 40 years, Du et al.,
2004), urbanisation (mass media, improved distribution infrastructure, large supermarkets and access to foreign suppliers, Hawkes,
2006), trade liberalisation (leading to increased supply of processed foods, growing urbanisation and changes in consumer lifestyle, Thow, 2009), trans-national food corporations (particularly
in the fast-food market, leading to ‘westernisation’ of lifestyles,
Hawkes, 2005) and improved food retailing (e.g. leading to rapid
expansion of supermarket networks, particularly in Latin America
and Asia; Reardon and Swinnen, 2004), are all implied.
The development of a national economy is generally accompanied by a subsequent decline in the relative output from the agricultural sector of that nation. Accompanying this shifting output
has been a signiﬁcant acceleration in globalised food trading due
to improvements in supply chains, international trading agreements and technology (Anderson, 2010). Changing demand for
food associated with demographic alterations within increasingly
large sub-populations of the globe leads to direct questions about
future food supplies and to so-called global ‘food security’. Food
security has been deﬁned as the scenario whereby ‘all people, at
all times, have physical, social and economic access to sufﬁcient,
safe and nutritious food to meet their dietary needs and food pref-
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Fig. 1. Global food security and projected production demands from the aquatic food sector in context. Expansion in the global population and associated demographic shifts
in particular regions lead to increased consumption of meat protein (included that from aquatic animals). Accelerated demand leads to further development of global trading
pathways. Production must expand to meet increased (and diversiﬁed) demand but limitations on wild capture place strong emphasis on farming of aquatic animals.

erences for an active and healthy life’ (FSN Forum 2007; http://
km.fao.org/fsn/). In the context of this, Godfray et al. (2010) states
that although globally 1 in 7 do not have sufﬁcient access to food, a
similar proportion is overfed. Furthermore, this increased demand
for food must be placed into context not only with concomitant increases in competition for land, water and other resources, but also
with exogenous factors such as climate change, all of which will affect how food is produced efﬁciently and sustainably. Global food
security, particularly in light of these factors must therefore be
considered an aspiration rather than a statement of reality, and
one that will require signiﬁcant multi-national engagement to be
achieved.
In terms of animal protein, terrestrial livestock systems occupy
about 30 per cent of the world’s ice-free surface area (Steinfeld
et al., 2006), are worth an estimated US $1.4 trillion, and employ
over 1.3bn people globally (Thornton, 2010). Global production
of protein from aquatic animals includes output from marine and
freshwater aquaculture (which has grown dramatically over the
past 50 years to supply over 50 million Mt at a value of US
$100bn per annum; Bostock et al., 2010), and from capture ﬁsheries which contribute 144 million Mt from marine and inland
waterways (Garcia and Rosenberg, 2010). In this context, it should
be recognised that aquaculture has grown faster than any other
food-producing sector over this period and is projected to supply
more than 50% of aquatic foodstuffs by 2015 (Bostock et al.,
2010). The Asian sub-continent dominates aquaculture production
(89% by volume, 79% by value), with China the largest producing
nation (>32 million Mt in 2008) (Bostock et al., 2010). In terms of
consumption of protein from aquatic sources (ﬁsh, shellﬁsh etc.),
the highest increases in seafood consumption have occurred in
Oceania and Asia, and especially in China where consumption
has increased from 11 g to 69 g per person per day over the period
1963–2003. In addition, developing nations have also markedly increased consumption of freshwater ﬁsh, with 10-fold increases in
countries such as China over the same period (Kearney, 2010). By
2050, aquatic production will need to reach 231 million Mt (almost
double the current production) to supply global demand (Kearney,
2010). In light of limitations of the ocean ﬁsheries to provide increased supply over this period, aquaculture, and particularly that

derived from the marine environment, has the potential to ﬁll the
deﬁcit and to provide the next food revolution (Duarte et al., 2009)
(Fig. 1).
Although the FAO state that over 300 species are farmed in the
global aquaculture industry, ﬁve species account for one third of
output by volume (19% value) and ten species for over half of volume (45% by value) (FAO, 2009). Of these key species, the FAO predict that annual production of wild capture and farmed
crustaceans (the focus of this review) exceeds 10 million Mt with
ﬁrst sale value of almost $40bn. Fisheries contribute approximately
60% by weight and 50% by value, with aquaculture production
forming the remainder. Fisheries are dominated by marine shrimp
($12bn), crabs ($3.7bn), lobsters ($2.4bn) and freshwater crustaceans ($1bn) (http://www.fao.org). Marine shrimp form the most
signiﬁcant proportion of the aquaculture sector (>3 m metric tonnes, ﬁrst sale value $12bn), with cultured freshwater crustaceans
($4.7bn), and other miscellaneous species contributing the rest
(data for 2006; http://www.fao.org). Whilst wild ﬁshery production has remained largely static, aquaculture production of key
species including Paciﬁc white shrimp (Penaeus vannamei) have
undergone rapid global expansion since 2000, ranking in the top
10 species by production quantity and number one for production
value ($9bn). Tiger shrimp (Penaeus monodon) adds a further $3bn
per year in production value (http://www.fao.org). Production of
cultured crustaceans is predominantly focussed in Central and
South America and Asia, particularly China. Consumption of product occurs more widely and exports are focussed on the USA, Japan
and the European Union. This geographic separation of net consumers from net producers in many cases, epitomises the globalised industry for crustacean food products and highlights the
status of shrimp as the most important seafood product traded
internationally (Stentiford et al., 2010b). With the backdrop of global production, this review will focus speciﬁcally on the issue of
food security from the wild and farmed crustacean sector, particularly with regard to the negative impact of pathogens on past and
current production, international legislative frameworks with the
potential to impact upon the trading of live crustaceans and their
products, and potential mechanisms to mitigate the effects of disease in farmed and wild populations. More comprehensive reviews
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Fig. 2. Key pathogens causing negative impacts in the global crustacean aquaculture and ﬁsheries sectors. Those marked with ⁄ are currently listed by the OIE (2012). (A)
Baculovirus penaei (BP). (B) Penaeus monodon nucleopolyhedrovirus (PemoNPV) (=Monodon Baculovirus, MBV). (C) Hepatopancreatic Parvovirus (HPV). (D) White Spot
Syndrome Virus (WSSV)⁄. (E) Taura Syndrome Virus (TSV)⁄. (F) Yellowhead Virus (YHV)⁄. (G) Infectious Hypodermal and Hematopoietic Necrosis Virus (IHHNV)⁄. (H)
Infectious Myonecrosis Virus (IMNV)⁄. (I) Necrotizing Hepatopancreatitis (NHP)⁄. (J) Crayﬁsh plague caused by Aphanomyces astaci⁄. (K) Hematodinium sp. dinoﬂagellate
parasites. (L). Microsporidian pathogens such as Hepatospora eriocheir (Stentiford et al., 2011).

of the speciﬁc diseases covered are available elsewhere in the
literature.

2. Diseases of crustaceans
Decapod crustaceans (including crabs, shrimp, lobsters and
crayﬁsh) can play host to a wide range of pathogens and parasites
(Fig. 2). Viral infections have been encountered in both wild and
cultured crustaceans; since their initial discovery in this host group
in the 1960’s (Vago, 1966), there have been over 50 viruses described from a diverse range of crustacean groups. Due to their larger size and characteristic pathology, the DNA viruses (epitomised
by the bacilliform viruses of the hepatopancreas of many crusta-

ceans, the white spot syndrome virus of penaeid shrimp, and the
virus infection of spiny lobsters, PAV1) have been described in
most host groups studied with any level of detail (for examples
see Takahashi et al., 1994; and Stentiford, 2008; Behringer et al.,
2011). Viruses with RNA genomes, some of which have devastating
consequences for cultured populations, are also being increasingly
described, particularly from intensively farmed penaeid shrimp
hosts (for examples see Boonyaratpalin et al., 1993; Hasson et al.,
1995; Poulos et al., 2006; Lightner, 2011). Whilst relatively little
is known about viruses of wild crustaceans, it is critical that as
much data as possible be collected on viral pathogens from wild
decapod stocks (Johnson, 1984; Bonami and Lightner, 1991).
Free-living bacterial infections of crustaceans are associated either
with the exoskeleton (e.g. Getchell, 1989), or the haemolymph
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(Tubiash et al., 1975; Wang, 2011). Intracellular bacterial infections occur within speciﬁc types of host cell (see Vincent et al.,
2004; Eddy et al., 2007). Fungal pathogens (Phycomycetes, Ascomycetes and Fungi Imperfecti) have been implicated in catastrophic epidemics and mortality events in decapod crustaceans
(Unestam, 1973). Egg mortalities and larval mycoses have been
associated with Lagenidium-like fungal infections in wild crabs
(Fisher and Wickham, 1975; Armstrong et al., 1976). Yeast infections co-occur with parasitic dinoﬂagellate infections in wild crabs
(Stentiford et al., 2003) whilst introductions of Aphanomyces astaci
has led to widespread mortalities in several European crayﬁsh species over the past century (Longshaw, 2011). Protistan pathogens
have been widely reported from crustacean hosts. A wide taxonomic spectrum of protists infect non-commercial hosts such as
the shore crab Carcinus maenas (Stentiford and Feist, 2005) while
several parasites within this group, including parasitic dinoﬂagellates of the genus Hematodinium, cause potent disease in an
increasing range of commercially exploited decapod crustaceans
(Stentiford and Shields, 2005; Morado, 2011; Small, 2012). Others,
including representatives of the Phylum Microsporidia (protistfungal border) are described infecting hosts across a wide range
of habitat types from freshwater to marine, and cause patent disease in affected hosts. The majority of infections infect either the
host musculature (e.g. Myosporidae, Stentiford et al., 2010b) or
the hepatopancreas (e.g. Hepatosporidae, Stentiford et al., 2011).
In some cases, microsporidium infections of crustacean hosts have
been demonstrated to have close relationships with those found
infecting vertebrate hosts (e.g. Enterospora in marine crabs, Stentiford et al., 2007, 2011), providing evidence for multi-trophic transfer between invertebrates and vertebrates. Finally, decapod
crustaceans are infected by a wide variety of metazoan parasite life
stages. These include worm infections by members of the Trematoda, Cestoda, Acanthocephala, Nemertea and Turbellaria, and the
parasitic crustaceans of the Copepoda, Rhizocephala and Isopoda.
Comprehensive surveys of metazoan parasites in wild crustaceans
were carried out during the late 19th and mid 20th centuries (see
Stentiford, 2008 for context) though recent interest in those with
zoonotic potential, such as the oriental lung ﬂuke (Paragonomus
westermanii) spark occasional interest in their presence in edible
crustaceans (Liu et al., 2007).
Viral pathogens appear to exert the most signiﬁcant constraints
on the growth and survival of crustaceans under culture conditions. However, the available literature indicates that protistan
pathogens appear to elicit the greatest detrimental effect in wild
crustacean hosts. These pathogens also affect the marketability of
commercial products harvested from these hosts. This may reﬂect
some artefact of the manner in which scientists approach the sampling of wild crustacean populations; in which rapidly lethal viral
pathogens, for example, may go relatively undetected. Recent work
focussing on the un-ﬁshed (juvenile) proportion of crustacean populations has furthermore demonstrated a signiﬁcantly different
pathogen proﬁle in these cohorts when compared with adults of
the same species; another potential contributor to so-called ‘silent
mortalities’ in wild crustacean populations (Shields and Squyars,
2000; Bateman et al., 2011).
Disease research in crustacean hosts is focussed on the utilisation of a combination of traditional (e.g. histopathology, transmission electron microscopy) and modern (molecular) diagnostic
approaches. As for other major animal groups, standardised protocols for the diagnosis of speciﬁc diseases of crustaceans are provided in the frequently updated Manual of Diagnostic Tests for
Aquatic Animals published by the World Health Organisation for
Animal Health (OIE, 2009). The pathogens currently listed in this
manual (and therefore notiﬁable to the OIE) are principally virus
infections of farmed penaeid shrimps, but the list is frequently reviewed to reﬂect emerging and persistent disease issues in farmed
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and wild crustacean hosts. Whilst the lack of continuous cell lines
for crustacean organs and tissues hampered fundamental research
into crustacean viruses, it has encouraged histopathological and
ultrastructural approaches to studying pathogenesis and pathogen
identiﬁcation. When combined with molecular approaches to
pathogen phylogeny, these methods have provided novel insights
into pathogen taxonomy based upon comparative morphological
and nucleic acid data (e.g. Stentiford et al., 2010b).

3. Diseases and the food supply from crustacean aquaculture
3.1. Where do disease agents come from?
The growth of the penaeid shrimp industry stems from early research into optimising husbandry conditions for shrimp growth
(mainly in Asia, between the 1930’s and 1960’s). This was followed
by commercial up-scaling from the late 1960’s and the early
1980’s, and international expansion of the industry in the subsequent period to date. The penaeid aquaculture industry is now
globalised, though principally conﬁned within the tropics to the region 15° north and south of the equator (Cheshire, 2005). The large
volume of published literature on the association between infectious disease agents and farmed penaeid shrimp provides compelling evidence for the major constraint that these pathogens have
imposed on efﬁcient production and yield in intensive aquaculture
systems (Lightner, 1993, 2011; Flegel, 2006a). Despite difﬁculties
in gathering accurate economic data on the effect of pathogens
on crustacean production, approximately 40% of potential tropical
shrimp production is estimated to be lost to infectious diseases
each year (Lundin, 1996). Around 60% of current disease-associated
losses in shrimp aquaculture may be due to viral pathogens with a
further 20% to bacterial pathogens. By comparison, losses associated with fungal and parasitic agents are less (Flegel, 2006b,
2012). In broad terms, since the inception of the industry, production has been plagued by an increasingly cryptic array of pathogens
that continue to emerge despite efforts to create speciﬁc-pathogen-free (SPF) stocks and apply improved farm management systems. Unfortunately, disease emergence and spread corresponds
to poor industry practice with potential to rapidly impact whole
regions. The propensity to house farmed stocks adjacent to (and
in direct contact with) natural waterways (and their resident wildlife) will likely further contribute to novel disease emergence, even
in originally SPF stocks of penaeid shrimp. In many such scenarios,
it cannot be deﬁnitively stated whether emergent diseases are indeed original pathogens of penaeid shrimp or opportunistic invaders from the surrounding fauna. Improved siting of farms in
biosecure settings will likely contribute to a reduced emergence
rate of signiﬁcant pathogens in penaeid shrimp (Flegel, 2012). In
other scenarios, diseases have emerged in penaeid shrimp following their feeding on non-penaeid carcasses. This pathway may
have been responsible for the emergence of WSSV in penaeid
shrimp hosts in Asia since shrimp broodstock in hatcheries were
commonly fed imported frozen crabs in the period prior to the outbreak. Morphologically similar viruses to WSSV have recently been
described infecting portunid crabs in Europe (Bonami and Zhang,
2011).
The emergence and trans-boundary distribution of pathogenic
agents associated with penaeid shrimp production is well documented within the existing literature, and brought up to date by
reviews contained within this volume, both for the Americas
(Lightner et al., 2012) and for Asia (Flegel, 2012). Prior to 1990,
due to limited trans-boundary movement of aquaculture animals
and their products, pathogenic agents affecting shrimp production
were largely conﬁned to speciﬁc geographic locations. For this reason, during the early industrial expansion of the industry, no
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Fig. 3. Global status of nations with historic reports of White Spot Disease (WSD) caused by white spot syndrome virus (WSSV) according to OIE ofﬁcial notiﬁcations (red) and
non-ofﬁcial reports (orange) at time of writing (www.oie.org). Initial outbreaks occurred in Marsupenaeus japonicus (Holthuis, 1980) (inset left) farmed in eastern Asia during
the early 1990’s. The subsequent pandemic caused by the virus (inset centre) reached Central and Southern Asia, Latin America and Southern Europe by the mid-late 1990’s.
Later the virus caused outbreaks in the Middle East. The ﬁrst ofﬁcial outbreak in Africa occurred in Mozambique in 2011.

shrimp diseases were listed by the World Animal Health Organisation (OIE). Subsequent expansion of the industry, and the increasingly globalised trade in broodstock, larvae and commodity
products arising from shrimp farming led to the emergence of several signiﬁcant disease conditions in both the Americas (e.g. Baculovirus penaei, necrotizing hepatopancreatitis, Taura syndrome,
infectious myonecrosis) and in Asia (spherical baculovirus, yellowhead disease, white spot disease). The majority of these diseases
have caused signiﬁcant production issues in shrimp farming regions distant from their original site of emergence. Furthermore,
some of them are listed by the OIE, highlighting their ongoing
importance as negative constraints to production and yield from
the industry. In addition, they have potential to affect non-farmed
populations of susceptible crustaceans (OIE, 2009; Stentiford et al.,
2009, 2010a; Lightner, 2012). It is also noteworthy that since 1993,
due to domestication and genetic stock selection of Paciﬁc white
leg shrimp (P. vannamei), that large-scale production has shifted
away from the formerly dominant black tiger shrimp (P. monodon)
(Flegel, 2012; Moss et al., 2012). Whilst domestication of stock is
clearly a major step forward in terms of yield improvement and
disease control at the farm and country level, it may also be argued
that the concentration of the majority of global effort into production of a single species of penaeid shrimp has certainly aided the
translocation of important pathogens to distant regions (e.g. infectious myonecrosis virus has been endemic in shrimp farms in Indonesia since 2006 following its emergence in Brazil in 2002). The
relative naivety of domesticated stocks of P. vannamei to novel geographic locations may also increase the potential for disease emergence in this translocated species, particularly where farmed stock
is maintained in ponds with direct contact to natural waters, and
their wildlife (see above).

3.2. White spot disease – a thorn in the side of global shrimp
aquaculture
White spot disease (WSD) due to infection with white spot syndrome virus (WSSV) provides the single most striking example of a
pathogen negatively impacting the production of food (and wealth)
from the crustacean aquaculture sector. Despite over two decades
since its emergence in Asia, WSD continues to plague shrimp the
major farming regions in Asia and the Americas, and to threaten
new locations where shrimp farming operations are in their infancy (OIE, 2009) (Fig. 3). Using data from several sources, Lightner
et al. (2012) predict that global production losses due to WSD have
been at least $8bn since its emergence in the early 1990’s but also
state that actual losses may be closer to $15bn. In this context, it
outweighs the impact of several other important crustacean pathogens currently listed by the OIE: IHHNV ($1bn), YHD ($0.5bn), TSV
($3bn) and IMNV ($1bn). Considering the higher end production
loss ﬁgure, this equates to an approximate $1bn per annum loss
to global shrimp aquaculture associated with WSD. Based upon
current annual production of $10bn, an estimated 10% of output
is lost each year to WSD alone. Taken together, the top ﬁve viral
pathogens (WSSV, YHV, TSV, IHHNV and IMNV) may account for
additional annual losses of approximately $500 m, giving an annual loss due to the top ﬁve viral pathogens of around $1.5bn (or
15% of production). Although ﬁgures stated are broad estimates
of losses incurred due to these pathogens, it is interesting to note
that although some viruses (such as IHHNV) appear to cause longer
term chronic losses to the industry (amounting to $ < 50 m per annum since emergence according to ﬁgures given by Lightner et al.
(2012), other pathogens, such as WSSV ($1bn per annum), TSV
($200 m per annum) and IMNV ($200 m per annum) continue to
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impart signiﬁcant annual negative effects. If one considers the 15%
production loss in terms of volume (currently estimated at >3 m
metric tonnes per annum), the top ﬁve viruses prevent production
of almost 500,000 metric tonnes of shrimp per annum, equivalent
to the total importation of shrimp products to the European Union,
or to the USA, in a year. In these terms, WSD alone accounts for volume losses amounting to 300,000 metric tonnes per annum, more
than the total importation to Japan within a year (Import ﬁgures
based upon 2006 in http://www.fao.org). Given population projections and considering maintenance of supply at the current rate,
the entire aquaculture industry output would need to double in
the next decade in order to keep pace with population growth
(FAO, 2009). Making a presumption that penaeid shrimp continues
to play a key role in this expansion, 6 m metric tonnes of production would be required by 2025. Considering current rates of production loss to WSD (10% of total) and the top ﬁve viral diseases
(15% of total), a shortfall equivalent to the current imports of the
whole of the USA and EU combined would be predicted. Given
worst case scenarios for tropical shrimp production losses by Lundin (1996) of 40% per annum, production shortfall would equate to
almost 3 m metric tonnes – the equivalent of total current global
production. To this end, the World Bank report recommended
investment of US$275 million in shrimp disease research over
the following 15 years (Lundin, 1996). Despite signiﬁcant advances
in understanding viral pathogenesis and mitigation of disease in
crustaceans, it is not clear whether this level of research investment has occurred to date.
3.3. Infectious myonecrosis virus – a lesson not learned
As stated above, expansion of the global shrimp farming industry between the mid-1980’s and the present day have aligned with
an increasing perception of the potential for trans-boundary movement of disease agents in broodstock, larvae and commodity products; especially for pathogens included in international legislative
frameworks such as that provided by the OIE (OIE, 2009) and the
EU (Stentiford et al., 2010a). However, despite this seemingly increased awareness, the rapid global spread of emergent pathogens
continues to occur. The emergence of Infectious Myonecrosis
(IMN) caused by infectious myonecrosis virus (IMNV) in Brazil in
2003, and its subsequent spread to P. vannamei farms operating
in Indonesia by 2006 epitomises the ‘lesson not learnt’ from previous experiences with illegal trading of infected broodstock (Flegel
and Fagan, 2002; Flegel, 2006c; Senapin et al., 2007). The emergence and global translocation of IMNV is a particular cause for
concern since it has rapidly established itself amongst the top ﬁve
viral pathogens and is likely to spread further through the Americas and Asia despite its listing by the OIE in 2005 (OIE, 2006). Estimated losses due to IMN in Indonesia already amount to over $1bn
and although Flegel (2012) predicts that IMN may not spread rapidly through Asia due to awareness on risks of broodstock and larval imports (including quarantine and testing for IMNV), illegal
movements cannot be ruled out and may more easily occur now
that the virus has been detected outside of South America. Flegel
(2012) also proposes that all Asian nations farming P. vannamei
should implement monitoring and emergency response procedures to deal with unexpected outbreaks associated with IMNV.
3.4. What is in store?
Domestication and the production of SPF stocks have undoubtedly led to signiﬁcant improvements in survival and yield, particularly when their ‘high health’ offspring are stocked into biosecure
facilities (Moss et al., 2012). The systematic appearance of commercially damaging viral epidemics in the years preceding such
initiatives is testimony to the potential for intensive stocking to
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convert cryptic viral infections to emerging disease problems in
captive penaeid shrimp. Maturation of the penaeid shrimp farming
industry over coming years will likely lead to greater emphasis on
the siting of farms in increasingly biosecure environments where
physical barriers protect farmed stock from wild reservoirs, and
vice versa (Moss et al., 2012). In this context, it is perhaps feasible
that the emergence rate of novel infectious agents of penaeid
shrimp will decrease to a level signiﬁcantly less than that observed
during the major expansive phase of the industry. Although other
avenues of disease introduction are possible, including potential
for industrial sabotage (see Jones, 2012), stringent control over
movements of live animals and their pathogens will remain a top
priority for those countries wishing to secure long term sustainability in their shrimp farming industry.
Expansion of the global crustacean aquaculture industry has not
solely relied on penaeid shrimp farming. Freshwater crustaceans
now contribute almost $5bn to global trade, with species such as
Macrobrachium spp. (300,000 metric tonnes per annum) and the
freshwater crab Eriocheir sinensis (almost 500,000 metric tonnes
per annum) being the key farmed species. Rapid expansion in culture of the latter was in direct response to an attempted diversiﬁcation in the Chinese industry (www.fao.org). As for penaeid
shrimp, the rapid growth in freshwater crustacean farming has
been blighted by several important disease issues. Macrobrachium
rosenbergii culture is impacted by the OIE listed M. rosenbergii
Nodavirus (MrNV) and its associated satellite, Extra Small Virus
(XSV) (Bonami and Sri Widada, 2011) which cause so-called White
Tail Disease (WTD) and mass mortality in hatcheries and farms
(Bonami and Sri Widada, 2011). E. sinensis has a number of pathogens, including a ronivirus causing ‘Sighs Diseases’ (Zhang and
Bonami, 2007), and an economically devastating infection by Spiroplasma eriocheiris which causes ‘Tremor Disease’ (Wang et al.,
2011). In other examples of non-penaeid crustacean culture, mud
crabs (Scylla spp.) are the subject of a rapidly expanding industry
in Asia and some parts of Africa, with production of over 138,000
metric tonnes ($377 m) in 2008. Culture of this species has been affected by several important pathogens in recent years, including
‘milky disease’ associated with the parasitic dinoﬂagellate Hematodinium (Li et al., 2008). Interestingly, this is the ﬁrst example of this
important pathogen of wild crustaceans (see below) causing negative effects in farmed crustaceans. Furthermore, recent work has
demonstrated how shrimp (Exopalaemon carinicauda) co-cultured
with crabs (Portunus trituberculatus and Scylla Serrata) in China
are also susceptible to infection by Hematodinium sp. (Xu et al.,
2010), with up to 100% mortality during outbreaks. The emergence
of Hematodinium sp. as a problem pathogen in Chinese aquaculture
is clearly a consequence of diversiﬁcation into novel aquaculture
species and is reminiscent of the emergence of non-viral pathogens
during early attempts to culture and upscale production of penaeid
shrimps (see above). The description of Hematodinium sp. infection
in E. carinicauda is the ﬁrst example of susceptibility to this pathogen in shrimp and likely reﬂects the speciﬁc stressors imposed
on E. carinicauda under intensive culture conditions. This example
shows the potential for novel pathogens to pass from species to
species under polyculture conditions and the role of wild reservoirs in disease emergence in aquaculture.
Finally, freshwater crayﬁsh farming is dominated by the production of red swamp crayﬁsh (Procambarus clarkii), principally
in China, the USA and Scandinavian countries. Global production
exceeded 500,000 metric tonnes during 2009 with ﬁrst sale values
of over $2.4bn. Although pathogenic agents have been reported
from P. clarkii, the extensive (rather than intensive) nature of their
culture has apparently averted serious disease problems
(www.fao.org). The expansion of this industry in other regions is,
however, somewhat limited by the vector potential of P. clarkii
for ‘crayﬁsh plague’ caused by A. astaci (Longshaw, 2011).
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4. Disease and food supply from crustacean ﬁsheries
4.1. Disease effects in wild stocks
The open nature of crustacean ﬁsheries coupled with a relative
lack of directed effort to survey for infectious agents and their
associated diseases has led to a signiﬁcant deﬁcit in knowledge
on causes of mortality in even our most commercially signiﬁcant
species. Dedicated ﬁeld surveys have focussed on the prevalence
of speciﬁc pathogens in ﬁshed populations of ﬁsheries species such
as European edible crab (Cancer pagurus) (Stentiford et al., 2002),
Norway lobster (Nephrops norvegicus) (Stentiford et al., 2001),
American lobster (Homarus americanus) (Stewart, 1975), brown
shrimp (Crangon crangon) (Stentiford et al., 2004), spiny lobster
(Panulirus argus) (Shields and Behringer, 2004), snow and tanner
crabs (Chionoecetes spp.) (Meyers et al., 1996). Other efforts have
attempted to gather ﬁeld data relating to the prevalence and proﬁle of pathogens over extended time periods or across different
seasons in a range of commercially and ecologically signiﬁcant species (e.g. Shields, 1993; Messick, 1998; Stentiford and Feist, 2005;
Shields and Overstreet, 2007; Stentiford, 2008). The majority of
studies to date have focussed on the presence of pathogens in
the ﬁshed portion of the population (i.e. the proportion over the
minimum landing size) since these animals are more convenient
to sample from either ﬁshers, or market places dealing in live animals for human consumption. Whilst these studies offer researchers an insight into the presence of pathogens in a given subpopulation, bias in the survey design linked to selectivity for or
against diseased animals via ﬁshing gear, pre-selection (removal)
of diseased animals by ﬁshers, and the potential for post-capture
mortality of animals with patent disease prior to sampling may
all affect the survey outcome (e.g. Pestal et al., 2003). Furthermore,
recent studies focussing on comparative pathogen proﬁles in juvenile and adult life stages of crabs (C. pagurus) have demonstrated a
propensity for higher prevalence and a different pathogen proﬁle
in these stages sampled over a whole year (Bateman et al., 2011).
Data of this type are likely to be important in understanding the
potential for disease to cause ‘silent mortalities’ (i.e. unobserved)
in commercially exploited crustacean stocks and may also be used
to develop cohort-to-cohort mortality models for ﬁsheries stock
assessment (e.g. Shields and Overstreet, 2007; Bateman et al.,
2011). Nevertheless, the ability to accurately assess the negative
contribution of disease to wild crustacean ﬁsheries in terms of production losses is far more challenging than similar assessments of
farmed crustacean stocks (see above).
With some notable exceptions (e.g. PaV1 infection of spiny lobsters), most reported cases of disease occurring at signiﬁcant prevalence in wild crustaceans relate to infection by protistan
pathogens. In particular, attention in the past two decades has focussed on the Hematodinium-like parasitic dinoﬂagellates infecting
a growing number of decapod crustacean species (for review see
Stentiford and Shields, 2005; Small, 2012). In the majority of hosts
studied to date, infection leads to a characteristic disease state in
which the haemolymph is progressively invaded by vegetative
and sporolative stages of the dinoﬂagellate. The disease has caused
signiﬁcant marketing issues in the industry for snow and tanner
crabs (Meyers et al., 1987), and is likely responsible for the total
collapse of ﬁsheries in some regions (e.g. Wilhelm and Mialhe,
1996). It is also being reported more frequently in species and
locations where presence and prevalence have been historically
low (e.g. Pestal et al., 2003; Shields et al., 2007). Whether this
represents an increased awareness (and therefore reporting) of
Hematodinium, or alternatively a true increase in its occurrence
in the global ﬁshery is debatable. However, evidence from certain
locations (e.g. the cold water ﬁshery for tanner and snow crabs

off Newfoundland) do provide clear evidence for signiﬁcantly
increased prevalence concomitant with changing ambient conditions in recent decades (Pestal et al., 2003). As stated above, it is
also signiﬁcant that Hematodinium has emerged as an important
pathogen of cultured crabs and shrimp in China in recent years
(Li et al., 2008; Xu et al., 2010). As highlighted by Small et al.
(2012), an improved understanding of the molecular taxonomy
of Hematodinium in the type hosts (C. maenas and Liocarcinus
depurator) and comparison to variants responsible for causing
disease in other important host crustaceans will be fundamental
in understanding the global epidemiology of this enigmatic parasite of wild crustaceans.
Continued focus on the pathogenic agents of wild crustaceans
has an important role in improving our understanding of emergent
pathogens affecting cultured stocks. Furthermore, the potential for
wild crustacean populations to tolerate very high prevalences of
pathogens (and their associated disease states) offers an intriguing
insight into the fundamental basis for host-pathogen interaction
and defensive responses in the invertebrates. In several cases,
infection prevalence may reach 100% (e.g. C. crangon bacilliform
virus in Crangonid shrimps; Stentiford et al., 2004, and Hematodinium sp. infection of blue crabs; Messick, 1994) without causing
long term decline of the host population. Diseases of wild crustaceans may therefore hold vital clues for mitigating the negative impact of pathogens in cultured crustaceans.
4.2. Can we mitigate the effects of disease in wild crustaceans?
Pathogens form a natural component of any ecosystem. In those
species of wild crustaceans that have been studied with any level
of detail, some appear to naturally harbour a wide diversity of
pathogens (e.g. C. maenas) (e.g. Stentiford and Feist, 2005) while
for others, the diversity of pathogens is lower (e.g. Homarus spp.)
(e.g. Cawthorn, 2011). Clearly such broad statements are somewhat subject of the number of published research papers associated with disease agents in speciﬁc host taxa (often governed by
their availability, ease of working with, and the ﬁnancial cost of
purchasing live samples), but broad experience on working with
a range of decapod hosts in our laboratories seems to reﬂect this
differential pathogen burden. For populations of some host taxa,
single pathogens appear to dominate the proﬁle (e.g. Hematodinium sp. in N. norvegicus; Stentiford and Neil, 2011) while for others,
including the aforementioned C. maenas, and the European edible
crab (C. pagurus), a wide range of pathogens may be encountered,
with certain ones occurring at high prevalence (>50%), and others
at lower prevalence (<5%) (Bateman et al., 2011). It is an oversimpliﬁcation however to consider that pathogens with lower observed prevalence may be less damaging to wild populations
than those occurring at higher prevalence. Cases of up to 100%
prevalence of CcBV infection in Crangonid shrimps (Stentiford
et al., 2004) may be less damaging for instance than a highly pathogenic viral infection such as PAV1 in P. argus (Shields and Behringer, 2004) which is detected at lower point prevalence in wild
populations, but likely leads to death of juvenile hosts (Behringer,
2012).
Several authors have considered the potential for anthropogenic
activities to alter the prevalence and outcome of pathogen infections of wild crustaceans. For example, in a review considering disease issues in the blue crab (Callinectes sapidus), Shields (2003)
states that in addition to direct mortality, indirect mortalities
may also occur whereby infected animals are somehow less able
to cope with exposure to other ambient stressors, or that fecundity
is reduced in diseased animals. He also highlights the problem facing those investigating disease in wild populations of crustaceans
when attempting to convince resource managers that disease af-
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Fig. 4. The chain of custody for wild crustaceans supplied to the live market. (A) Following capture and landing by ﬁshers (inset), live crustaceans, can be transported in water
to market via road. (B) Typical ‘live well’ in a truck transporting live crustaceans (Maia squinado) from the UK to continental Europe. (C). Live animals are retained prior to
market in holding facilities, near market, within the recipient country (D) European edible crabs (Cancer pagurus) in a live holding facility in continental Europe. (E). New
markets (e.g. to Asia and Europe from Canada and the USA) can be serviced by airfreight of live animals in water-free containers, directly to holding facilities within recipient
countries, or even directly to consumers via sale in airport lounges (F).

fects ﬁsheries yield. In this context, the role of disease as a contributory factor to mortality may far exceed the standard contribution
of 20% as proposed in the majority of ﬁsheries stock assessment
models.
In terms of mitigating the negative impact of disease in wild
populations of crustaceans, simple approaches such as the landing (and destroying) of patently diseased animals, the reduction
of landing restrictions in epizootic years, overﬁshing of affected
regions or the speciﬁc targeting of certain sexes (in which disease
prevalence is highest) have all been proposed (Kuris and Lafferty,
1992; Shields, 2003, 2012). Murray (2004) used a classical epidemiological model to examine how harvesting strategy may inﬂuence the impact of an epidemic spreading as a spatial wave
through a wild ﬁsh population. The impact of pre-epidemic harvesting depends on the nature of the disease. If a signiﬁcant fraction of the post-epidemic population would have consisted of ﬁsh
which were never infected, the post-epidemic population can be
enhanced by pre-epidemic harvesting. However, as also noted
by Shields (2003), we still lack fundamental knowledge on key as-

pects of the life history of important pathogens (such as the disease status of the post-epidemic population and transmission
route of Hematodinium sp.) and importantly, on the mortality
associated with certain agents. Relatively long term monitoring
of crustacean populations has occurred for some important
pathogens (e.g. Hematodinium sp. in Scottish populations of N.
norvegicus; Stentiford et al., 2001) and in such instances, there
is evidence that ﬁshing pressure is likely to have altered the stock
structure to be more conducive to epidemics (i.e. larger proportions of small, simultaneously moulting lobsters). In many
exploited populations harvesting accounts for a large fraction of
mortality. If ﬁshing take is at or close to maximum sustainable
yield there is no spare capacity to absorb losses due to disease
outbreaks. An improved understanding of the role of ﬁshing activity on stock structure (and disease prevalence) may therefore be
utilised to avert future epidemics by altering ﬁshing patterns in
deﬁned regions. Such approaches require closer collaboration
and aligned ﬁeld sampling programmes by ﬁsheries biologists
and disease researchers.
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4.3. Losses associated with disease in the post-capture phase
In contrast to many other wild capture species, a signiﬁcant
proportion of crustaceans captured by ﬁshers is transported live
to market for subsequent human consumption (Fig. 4). In some nations (e.g. Portugal), the live trade in marine crustaceans from
other European nations contributes the majority proportion of national sales. The trade itself involves a complex chain of ﬁshers,
road transportation and holding facilities which precede purchase
and consumption of live products (Barrento et al., 2008). In other
scenarios, live animals are shipped to distant markets via road
and air following prolonged holding in the post-capture phase. In
such instances, animals are often retained until market conditions
are favourable (in some cases >6 months after initial capture), a
particular strategy adopted by the globalised American and Canadian lobster industries, now worth over $1bn, with annual landings
approaching 100,000 tonnes (see Cawthorn, 2011; Fotedar and
Evans, 2011). The live market chain is however fraught with potential stressors (poor initial selection of animals, air exposure, hypoxia, handling and physico-chemical disturbances), all of which may
impact upon delivery of high quality animals to market. To this
end, losses of up to 66% have been reported for live holding facilities for decapod crustaceans (for context see Barrento et al., 2008).
As a result, annual losses in this phase contribute signiﬁcantly to
the unsustainable exploitation of wild stocks and have signiﬁcant
impact on future food security via this market route. To this end,
several workers have highlighted the critical stages in the market
chain which contribute to elevated mortality and have proposed
mechanisms to reduce post-capture losses (and thereby improve
animal welfare) associated with this trade (for review see Fotedar
and Evans, 2011).
Several important diseases have been reported to occur in crustaceans, speciﬁcally within the post-capture phase. Gaffkemia
(caused by the bacteria Aerococcus viridans) and so-called ‘Bumper
Car Disease’ (caused by the ciliate Anophryoides haemophila) occur
during the post-capture storage of H. americanus and are at least
partly responsible for the 10–15% losses occurring annually in this
industry (Lavallée et al., 2001; Cawthorn, 2011). Other infectious
agents causing problems in the post-capture phase include Hematodinium sp. in Scottish N. norvegicus which has had direct negative
impacts on the post-capture transportation of live animals to market, and has led to altered post-mortem degradation and earlier
organoleptic rejection of product (Neil, 2012). Non-infectious conditions have also signiﬁcantly affected the live trade in N. norvegicus – the cumulative effects of capture, emersion, handling and
poor post-capture holding conditions causing so-called Idiopathic
Muscle Necrosis (IMN) in a potentially large proportion of the
catch (Stentiford and Neil, 2000; Ridgway et al., 2006, 2007). It is
clear that the current practice of live post-capture storage of crustaceans is generally deemed a high-risk sector of the market and
one that leads to signiﬁcant mortalities and lower prices being paid
for live commodity to ﬁshers. In some regions (such as Europe),
this has led to severe depressions in the unit price of live animals,
which when combined with limited landing restrictions for certain
species (e.g. C. pagurus), has formed a quantity, rather than quality
ﬁshery. Whether this practice is considered sustainable alongside
increasing pressure on invertebrate ﬁsheries resources is open to
debate.
5. Managing and mitigating the problems
5.1. A shared responsibility between producer and consumer nations
The diagnosis of emerging disease issues and the rapid enforcement of biosecurity measures to avert the subsequent spread of
pathogens are central to the prevention of regional or international

epidemics in crustacean aquaculture. In this context, an efﬁcient
National Veterinary Service is central to the global ‘public good’
represented by animal health systems. Although inherent within
the protocols and manifestos of organisations such as the OIE
(OIE, 2009; Lightner, 2012), and written into the international legislation of some regions such as the EU (Stentiford et al., 2010a;
Peeler, 2012), important emergent pathogens (most recently,
IMNV) continue to rapidly disseminate around the globe via existing trade pathways. The OIE is recognised by the World Trade
Organisation (under the Agreement on the Application of Sanitary
and Phytosanitary Measures; the SPS Agreement) as the reference
organisation for setting of international standards dealing with
animal health and zoonoses (see Oidtmann et al., 2011 for context).
In terms of aquatic animal health, the OIE Aquatic Animal Health
Code aims to assure the sanitary safety of international trade in
aquatic animals (amphibians, ﬁsh, crustaceans and molluscs) and
their products. This provides health measures to be used by Competent Authorities of importing and exporting countries to prevent
the transfer of agents pathogenic for aquatic animals or humans,
while avoiding unjustiﬁed sanitary barriers (Oidtmann et al.,
2011). In 2011, the OIE had 178 member countries. The OIE International Database on Aquatic Animal Diseases (IDAAD) hosted by
the OIE Collaborating Centre for Information on Aquatic Animal
Diseases (http://www.cefas.defra.gov.uk/idaad/) publishes data
on the occurrence of the OIE-listed aquatic animal diseases
(including those of crustaceans) in all member countries. The data
are grouped into ‘OIE data’ (ofﬁcial notiﬁcations by member countries to the OIE) and ‘non-OIE data’ (non–ofﬁcial data for a speciﬁc
country, published in the scientiﬁc literature). It is interesting to
note that for speciﬁc crustacean diseases (e.g. WSD) ofﬁcial notiﬁcations (28 countries in ﬁve host species under natural occurrence)
is signiﬁcantly short of the 40 countries in 42 host species under
natural occurrence when ‘OIE data’ and ‘non OIE data’ is taken together (see Fig. 3). This reﬂects the considerable under-reporting of
notiﬁable diseases to the OIE by member country Competent
Authorities (Lightner, 2012). The cause of this under-reporting
has several potential causes. In some cases it is due to a lack of
expertise with regard aquatic animal diseases within the Veterinary Services of the member country (Lightner, 2012). In other
cases, it may reﬂect the politics surrounding the reporting of such
diseases with regard to the perceived effect that such reporting
may have on the international trading of animals and their products. Another case may be the lack of resources available for testing
and controlling for these diseases.
Increasing focus on the control of trans-boundary movements
of crustacean pathogens is also reﬂected in recent changes in regional legislation. Within the EU, Council Directive 2006/88/EC
adopted during 2008 has introduced controls for crustacean disease at the European level for the ﬁrst time. It lists three crustacean
diseases (WSD, YHD and TS) in recognition of their global importance in causing signiﬁcant economic losses and the potential for
their international transfer via transboundary trading in live animals and their products (Stentiford et al., 2010a). Whilst movements of live aquatic animals offers the most efﬁcient means for
global distribution of pathogens, studies have also demonstrated
the potential for introduction of novel hosts in new geographic regions via trading in aquatic animal products, particularly where climatic regimens in receiving countries are suitable for pathogen
survival and replication (Durand et al., 2000, 2003; Reville et al.,
2005; Hasson et al., 2006; Bateman et al., 2012; Jones, 2012). Taken
together, the expansion of crustacean aquaculture into new regions, the wide host susceptibility range to certain pathogens (such
as WSSV) and the signiﬁcant international trade in raw, frozen
commodity products have lead to a wider appreciation of the negative impacts of (in particular) penaeid shrimp pathogens, in temperate regions. Based upon the fact that such regions (EU, USA,
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Japan) are also the primary markets for these products, it is clear
that future efforts for minimising the negative impact of disease
is not only directed at those countries in which culture industries
are based but also where products are destined. A central issue
for health-related global public goods is how best to ensure that
such collective action for health is indeed taken at the global level.
Furthermore, investment into disease mitigation strategies that
promote a sustainable food supply from the aquatic sector is a
responsibility of both governments and those appropriate industries in net producing and net consuming nations.
5.2. Improving knowledge on pathogens and their spread
The wide range of aquatic animals in culture combined with
important anthropogenic drivers (such as the long-distance movement of live animals and their products and certain farming practices) have been implicated in the relatively high rate of disease
emergence in aquatic animals compared to those farmed on land
(Peeler and Feist, 2011). Although the initial source of an emergent
pathogen (and its associated disease state) is often not well documented, it can be assumed that they arise either from a change in
the virulence of endemic pathogens, an altered ambient status
which permits patent disease to occur, or from transmission to
new hosts via close contact between populations of the same or
different species in adjacent wild and culture settings. Enhanced
disease surveillance and monitoring of wild crustacean stocks continues to demonstrate the expansive proﬁle of pathogens infecting
decapod crustaceans (see above) but to date, few of these surveys
have included wild species residing in habitats adjacent to aquaculture sites. Surveys of this type provide an inventory of endemic
pathogens occurring in hosts from natural habitats and may therefore be utilised to assess the potential risk of transfer of pathogens
to cultured hosts. In lieu of novel pathogen emergence in cultured
hosts, the inventory may also be used to document the potential
ﬁrst occurrence and act as a mechanism to limit its dispersal to
new sites. An understanding of the pathogens inherent within
these systems is however only one part of the equation. Several recent commentaries on the potential for disease outbreaks in open
ocean systems have questioned whether we are experiencing an
increased emergence rate concomitant with various environmental
forcing factors such as climate change or anthropogenic pollution
(Lafferty et al., 2004), or whether the emergence simply reﬂects increased observation and our relative lack of understanding of pathogen diversity (e.g. see Suttle, 2007). In light of such reviews, it will
be increasingly important to consider diseases caused by pathogens as an outcome of the interaction of host, pathogen and environment rather than simply the inherent virulence of a given
pathogen per se. Such evidence is already well understood in certain aquaculture scenarios where high prevalence of a given pathogenic agent does not necessarily equate to disease and mortality
in infected hosts; rather that environmental forcing factors alter
the potential of the host to limit pathogen replication (see Walker
et al., 2011 for example). It is evident therefore that understanding
the potential for ‘disease’ rather than just ‘infection’ will be instrumental when assessing the risk associated with emergence of novel pathogens or further spread of those already known. In
addition to natural and anthropogenic forcing factors, for crustaceans, the potential for development of disease is also strongly
associated with basic features of host life history such as moult status, condition, sex and age (for example, see Bateman et al., 2011).
5.3. Harnessing the natural disease mitigation strategies of
crustaceans
Certain crustacean hosts appear to naturally harbour a wide
diversity of pathogens while for others, the diversity of pathogens
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is considerably less (see Section 4.2). Furthermore, of those pathogens encountered, some occur at relatively low (<5%) prevalence
while others may be present in almost every individual sampled
from a natural population. As previously stated, this observed variation in proﬁle and prevalence may be inﬂuenced by vagaries in
sampling design, or even the level of historic effort afforded to certain species. However, broadly speaking, at least part of this variation is based upon an inherent differential ability for speciﬁc
pathogens to transmit, infect, replicate, cause disease, and mortality in speciﬁc host taxa. While numerous examples exist of this differential ability in the literature, a comparison of host
susceptibility to the viral pathogens WSSV (many taxa across the
Order Decapoda), and TSV or YHV (generally considered more speciﬁc to certain taxa) demonstrates a clearly different host-pathogen interface in these examples (Stentiford et al., 2009). To
complicate matters further, recent studies on pathogen proﬁle
and prevalence in juvenile and adults of the same species of crab
(C. pagurus) demonstrate how susceptibility to infection and disease alter throughout the lifetime of a given species (see Bateman
et al., 2011). Broadly speaking, defensive responses by a host are
therefore in part governed by inherited factors (which deﬁnes ‘species-level susceptibility’) and by more subtle mechanisms developed during the lifetime of the host (deﬁning ‘life-stage
susceptibility’). As discussed above, the latter may be further affected by environmental factors which in some create sub-optimal
physiological conditions for the species and life stage in question.
Taken together, the interaction of pathogens with wild crustaceans
from across this natural spectrum likely holds fundamental clues
for ways to mitigate disease in aquaculture. For example, studies
of relatively resistant host species or life stages (e.g. to key pathogens such as WSSV) may offer more fruitful avenues of research
than studying those species (and life stages) for which natural
resistance to viral replication and development of disease are
negligible.
Hauton (2012) reviews potential approaches to the manipulation of the host immune response for the purpose of prophylaxis
in aquaculture. He states that to date, efforts have largely centred
on the delivery of various pathogen associated molecular patterns
(PAMPs) and the successive measurement of various immune
effectors (e.g. proPO) at the gene or protein levels. However, he
also states that these approaches are considered somewhat crude
and likely impose a net energetic cost to the host (see also Smith
et al., 2003; Christensen et al., 2005; Hauton et al., 2007). Hauton
(2012) therefore states that in an aquaculture setting, ‘(that this)...blunt approach cannot serve as a global solution to the problems of
commercially signiﬁcant diseases’. As such, effective disease therapies can only be developed through a detailed understanding of
the molecular pathways involved in immune surveillance within
these hosts. In this respect, observations of pathogen handling in
wild populations may be utilised to identify markers of immune
performance that could have direct relevance for application to
farming situations. Hauton (2012) summarises by identifying ﬁve
potential avenues for research development: (1) Investigations
into the diversity of potential immune receptors and regulatory
pathways (such as DSCAM). (2) Studies on the broad spectrum of
antimicrobial peptides produced by crustaceans. (3) Understanding the basis for haemocyte proliferation in vitro. (4) Understanding the role of the gut in subsequent immunity and disease
states; and ﬁnally. (5) Molecular studies of host-pathogen interaction (epitomised by recent advances with viral interference and
RNAi strategies).
Speciﬁcally for the latter example, in their paper, Bartholomay
et al. (2012) have demonstrated that augmentation of the RNA
interference (RNAi) response in shrimp to suppress virus infection
and associated disease is a promising, emerging approach to
shrimp virus disease control. Here, short fragments of RNA recog-
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Fig. 5. Typical mangrove-based shrimp farm for Penaeus vannamei in Latin America. (A and B) post larval rearing prior to stocking of open air ponds. (C) grow-out period in
open air ponds separated from each other and from the surrounding mangrove by levees. (D and E) health assessments occur at regular intervals during the growout phase
(typically lasting approximately 120 days to produce shrimp of up to 20 g). (F). Ponds are drained following harvest and may be left for a fallow period prior to re-stocking.
Two or even three crops may be possible in a single year.

nise and bind complimentary dsRNA sequences, thereby preventing speciﬁc gene expression (e.g. in a virus) in a sequence-speciﬁc
manner. It is thereby envisaged that natural RNAi pathways play a
critical role in the arthropod innate immune response to virus
infection and therefore offer signiﬁcant potential for development
into prophylactics for use in aquaculture (Bartholomay et al.,
2012). Signiﬁcant challenges do however exist in the fundamental
understanding of molecular responses to viral challenge, the propensity for high-prevalence/low-disease conditions in shrimp
farms, the simultaneous occurrence of multiple viral infections
(and strains) within individual hosts and pond populations and signiﬁcantly, the ability to deliver any potential therapeutic in an
effective vehicle that offers long term protection during the grow
out phase. These are all areas requiring considerable intellectual
focus in coming years.
5.4. Improving husbandry and farm management
In contrast to approximately 35 species of bird and mammal
that have been domesticated for use in global agriculture and
food production (FAO, 2007), an estimated 300 species are farmed

in the global aquaculture industry, and many more are subjected
to capture ﬁsheries (FAO, 2009). However, in terms of crustacean
aquaculture, truly domesticated species (with continuous controlled reproduction independent from input of wild stock) are
somewhat limited, with an almost total global reliance on a handful of penaeid shrimp species with relatively short domestication
histories. Of these, two species P. vannamei and P. monodon support the majority of the $12bn per annum global industry (Fig. 5).
Early operations with penaeids utilised wild captured broodstock
to produce offspring, or even direct stocking of ponds with larvae
collected from nursery habitats in coastal margins of tropical
zones. Whilst important in gaining early ground in the movement
of penaeid shrimp to a globally traded commodity, this practice
was almost certainly responsible for signiﬁcant losses due to disease during this initial period (see Moss et al., 2012). The use of
wild stocks has now generally been superseded by a reliance on
domesticated penaeid shrimp lines, often possessing beneﬁcial
traits for commercial rearing (such as SPF classiﬁcation for key
viral pathogens). It is without doubt that this transition has been
largely responsible for the massive growth in global yield from
this sector in recent decades (Moss et al., 2012; Lightner et al.,
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Fig. 6. Commodity products traded to the European Union from the global crustacean aquaculture sector. (A) Whole, frozen raw tiger shrimp (Penaeus monodon). (B) Whole
raw, unfrozen whiteleg shrimp (Penaeus vannamei). (C) Whole, ice packed portunid crabs (species unknown). (D) Frozen en bloc, raw tails of P. vannamei sold in the wholesale
market. Individual Quick Frozen (IQF) tails are more commonly sold in the supermarket retail sector.

2012). In his review, Moss et al. (2012) lists the use of SPF
shrimp, improvements in selective breeding, and the adoption
of strict on-farm biosecurity practices as key requirements for future expansion and long term sustainability of the global shrimp
industry.
In relation to mitigating the negative impact of disease, Moss
et al. (2012) also highlight that although SPF lines are free from
speciﬁcally listed pathogens (often those listed by the OIE), they
should not be considered ‘pathogen free’ (e.g. it is difﬁcult to exclude Vibrio spp. associations from SPF shrimp lines), nor innately
resistant to those listed pathogens (even though in some circumstances, resistance traits may be bred into shrimp lines through
selective breeding). Due to these inherent features, an integrated
approach to on-farm biosecurity is required even when ponds are
stocked with high health fry that originate from SPF stocks and
may also be disease which maximise the potential for successful
grow-out. Moss et al. (2012) state the role of inﬂuent water as the
most signiﬁcant pathway of pathogen entry into the farm system
(a particular issue where farms are sited close the coast). More
recent attempts to intensively farm shrimp with zero water exchange (that also exclude crustacean pathogen vectors via screens
and water treatment) is the so-called Bioﬂoc technology (BFT)
that has successful yielded crops of up to 20 metric tonnes per
hectare (Taw, 2010). Moss et al. (2012) summarise by proposing
that an increased focus on integrated management practices
(e.g. stocking of high health fry originating from SPF shrimp
stocking into BFT farms) allows breeders to focus selection pressures on growth and growout survival, rather than disease resistance, and this may lead to increased production and proﬁtability
for the farmer. Isolating the farm system in this manner is likely
to have direct beneﬁt by limiting pathogen spread from farmed to
wild stocks.

5.5. Deﬁning the risk of disease translocation in commodity products
As described in the forgoing text, the global trading of shrimp
products is well established, with up to 60% of all commercially
harvested shrimp being placed on the world market (Anderson,
2010; Gillett, 2008; Walker and Winton, 2010) (Fig. 6). Given the
apparent high propensity for viral infections to occur in penaeid
shrimp, and the documented survival of such viruses within raw
frozen commodity products (Nunan et al., 1998; Durand et al.,
2000; McColl et al., 2004; Reddy et al., 2011), the speciﬁc risks
associated with the trading of raw product is being afforded increased attention (Stentiford et al., 2010a). In his review, Jones
(2012) provides a synopsis of current opinions on the topic. Here,
it is stated that the international movement of animals and their
products is governed by the General Agreement on Tariffs and
Trade (GATT), and the associated Sanitary and Phytosanitary Measures (SPS Agreement) of the World Trade Organisation (WTO).
Responsibility for the technical issues associated with application
of the SPS agreement are then vested in the World Organisation
for Animal Health (OIE). Jones (2012) describes several instances
where the translocation of important viral pathogens to new locations was not due to the movement of live animals. These include
the outbreak of WSSV in Darwin, Australia in 2000 (East et al.,
2004) and the outbreak of WSSV in Louisiana crawﬁsh ponds in
2009 (Baumgartner et al., 2009). Furthermore, he states that in
addition to the direct use of raw frozen products as aquarium/farm
animal feeds, other potential pathways of introduction include discarded waste from crustacean processing plants, the use of commodity shrimp as angling baits, or even by industrial sabotage.
Of these, the use of shrimp as angling baits via the diversion of
product packaged for human consumption was identiﬁed as a common practice in the Import Risk Assessment carried out in Austra-
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lia (Biosecurity Australia, 2009). However, Jones (2012) recognises
that even in the event of pathogen introduction via this (or similar)
means, the probability of establishment of infection in a naïve susceptible host is not easy to predict. Furthermore, calculation of
likelihood of passage of an established infection to other susceptible hosts within the population or an ecosystem is harder still. To
this end, it was noted that even though WSSV was discovered in
the Darwin aquarium facility in Australia in 2000 and the initial
surveys of wild crustaceans at the facility outlet also tested positive for WSSV by PCR at the time, subsequent testing of animals
at the site returned a negative result (East et al., 2004). Taken together, such evidence, and that arising from several other laboratory studies, appears to demonstrate that a pathogen with a wide
host range (such as WSSV) present within commodity product
can be passaged to naïve hosts via normal use pathways (feeding).
However, the likelihood for establishment of infection at the individual or population level, and importantly, the consequence of
establishment for naïve wild populations, is not fully understood
(Flegel, 2009). In addition, the likelihood of transmission and
establishment appears to be further diminished in the case of relatively host speciﬁc pathogens (such as YHV) (Sritunyalucksana
et al., 2010).
In spite of concern over the OIE listed pathogens, Jones (2012)
argues convincingly that in numerous cases (particularly as experienced for molluscan pathogens), by the time ‘‘epidemiological
signiﬁcance’’ of a non-listed novel pathogen is recognised (a
requirement by the OIE for notiﬁcation of a non-listed pathogen
according to Article 1.1.3.5 of the Aquatic Animal Code), the pathogen may have since spread to distant locations at which its potential effect may be more devastating than estimated from the initial
description. However, countries can take measures against diseases which are not listed, and the OIE can list ‘emerging diseases’
for which the criteria of ‘epidemiological signiﬁcance’ are not required. As a result, in addition to the clear legislative measures
which aim to control the movement of live animals for use in aquaculture (e.g. see Stentiford et al., 2010a), any other measure to reduce the risk of translocating known or unknown pathogens via
the trading of commodity products, without forming signiﬁcant
barriers to trade, should be welcomed. These include various Codes
of Practice, packaging of products to avoid their diversion to high
risk activities (such as angling), public education (via labelling
and other routes) and end-user regulations such as prohibitions
on use as bait (Jones, 2012). Since the majority of these measures
are likely to occur post-importation, they will become the primary
responsibility of importing nations. In the likely event that these
additional measures entail added costs of importation, increased
demand for commodity products arising from low-disease risk
operators (or countries) is likely to become de rigueur (Stentiford
et al., 2010a). In essence, as raised is Section 5.1, the responsibility
for control of transboundary disease spread will increasingly be
shared by producer and consumer nations.
5.6. Learning lessons
The increased perception of risk for the trans-boundary movement of pathogens in broodstock, larvae and commodity products
via the inclusion of such pathogens within international legislative
frameworks of the OIE and other bodies (such as the EU) is a vital
tool for reducing the effects of these pathogens on global aquaculture and ﬁsheries production. In addition, FAO initiated regional
programmes, such as the ‘Better Management Practices’ approach
of the Network of Aquaculture Centres in the Asia–Paciﬁc (NACA)
bring pragmatic training to the industry and have a clear role to
play in increasing awareness of issues such as disease for farm productivity, proﬁt, and ultimately the marketability of aquaculture
products to foreign markets. The NACA programme also recognises

the role of sustainable aquaculture in developing rural communities via capacity building, education, training and collaboration
(www.enaca.org). It is encouraging to note similar FAO-led activities to establish a ‘Network of Aquaculture of the Americas’ (http://
www.racua.org) and the ‘Aquaculture Network for Africa’ (ANAF)
(www.anafaquaculture.org). The latter initiative, which provides
a virtual linkage between 10 African nations, is timely given that
Africa, which currently contributes just over 1% of global aquaculture production, clearly offers signiﬁcant future potential for
expansion. (www.fao.org). In this context, ANAF aims to promote
the development of the African aquaculture sector at national
and regional levels and to do so in a sustainable manner. The recent outbreak of WSD in penaeid shrimp farming operations in
Mozambique (the ﬁrst outbreak of this disease in Africa) sends a
clear warning of the potential for this expanding industry to be impacted by the known listed pathogens (www.oie.org). Furthermore, the farming of shrimp (and other species) in new locations,
entails signiﬁcant risks for emergence of novel diseases from the
rich pathogen biodiversity that resides in the natural waterways
of those areas. Like NACA, regional initiatives in other regions must
work alongside trans-global legislative instruments to ensure that
aquaculture animals reach the end of the production cycle and that
traded commodity is as safe as possible with regards pathogen
status.

6. Conclusions and policy implications
The Organisation for Economic Co-operation and Development
(OECD) has a primary mission to promote policies that will improve the economic and social well-being of people around the
world. In this context, the topics discussed in this review provide
a clear statement that despite a recent dramatic expansive phase
in global crustacean aquaculture production, and the ongoing,
widespread exploitation of natural stocks of crustaceans from the
global ﬁshery, sustainable food production from the sector will require careful attention to the current and future issues which will
limit production. Furthermore, in light of a rapidly changing global
socio-economy, demand for products arising from these sectors
will increase. Although not a stand-alone topic, the issue of disease
mitigation is central to the delivery of increased yield from the sector. The success of aquaculture and ﬁsheries products reaching the
market place will therefore become a key concern for both net-producing, and net-consuming nations.
In the recent OECD-funded symposium on ‘Disease in aquatic
crustaceans: problems and solutions for global food security’ key
topics relating to current and future disease issues facing the sector
were discussed. The detail of these discussions is broadly represented in the papers that follow from this review but are brieﬂy
summarised below:
Losses in farmed crustaceans are mainly associated with viral
pathogens for which standard preventative measures (such as vaccination) are not currently feasible. In light of this problem, new
approaches to enhancing yield including improvements in broodstock and larval sourcing, outreach to farmers for promotion of
best management practices, and cutting-edge research that aims
to harness the natural abilities of invertebrates to mitigate assault
from pathogens (e.g. the use of RNA interference therapeutics), are
urgently required. In terms of ﬁsheries losses associated with disease, key issues are centred on mortality and quality degradation
in the post-capture phase, largely due to poor grading and handling
by ﬁshers and the industry chain. Occurrence of disease in wild
crustaceans is also widely reported, with some indications that climatic changes may be increasing the susceptibility of exploited
species to important pathogens (e.g. the parasite Hematodinium).
However, despite improvements in ﬁeld and laboratory diagnos-
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tics, deﬁning population-level effects of disease in these ﬁsheries
remains elusive. Coordination of disease specialists with ﬁsheries
scientists will be required to understand current and future impacts of existing and emergent diseases on wild stocks.
Overall, the increasing demand for crustacean seafood in light of
a high emergence rate of novel diseases, a limited ability to mitigate the disease process in farmed animals, poor post-harvest handling of wild animals, and an increasing legislative burden on the
trading of live animals and their products, signals a clear warning
for the future sustainability of this industry. The linking together of
global experts in the culture, capture and trading of crustaceans
with pathologists, epidemiologists, ecologists, therapeutics specialists and policy makers in the ﬁeld of food security will allow
these bottlenecks to be better identiﬁed and addressed.
Key policy-related outcomes are:
1. An increased focus is required on effective therapeutics for
invertebrate pathogens and speciﬁcally those disease-causing
agents affecting food production from aquaculture. Research
effort is required not only in those countries where production
occurs but also in those countries where consumption is centred. Trans-national research programmes, including those
funded by government which promote the ‘public good’ arising
from aquaculture should aim to combine appropriate scientiﬁc
expertise with practical approaches to aquatic animal production in the ﬁeld.
2. An increased focus is required on the production of domesticated crustacean lineages that possess SPF or resistance traits
that provide positive beneﬁt for food production. Increasing
diversity of high-volume farmed crustacean species (e.g. in
China) places a speciﬁc emphasis on development of domesticated sources for production, particularly in light of a poorly
described pathogen fauna for these hosts. Furthermore,
increased focus on Best Management Practice (to encompass
strong biosecurity principles) and novel approaches to highvolume production (e.g. Bioﬂoc systems) require dedicated
research effort.
3. An increased focus is required on the signiﬁcant wastage inherent in supply chains for live crustaceans arising from the global
ﬁshery. In some regions (e.g. EU, Canada, USA), live movement
to market represents a signiﬁcant proportion of total trade.
Losses due to poor grading, handling, storage and transport
have led to a quantity-based ﬁshery rather than quality-based
industry. Spiralling lower prices arising from trading in this
high-risk product have led to systematic over-exploitation
(often in ﬁsheries for which no quota exists).
4. An increased focus on rapid response to known and emerging
disease outbreaks is required. Action is needed at all levels of
the stakeholder chain (from producers through to national government Competent Authorities) to ensure that appropriate
measures are taken to avert the introduction of pathogens, or
in case of their emergence, to report and mitigate rapidly. Effective trans-national legislative tools exist but are often slow to
act, leading to rapid dissemination of the pathogen of concern.
Shared responsibility programmes should emerge whereby producer nations aim to supply low disease status commodity and
consumer nations introduce appropriate post-import controls
to prevent live animals and their products coming into contact
with local wildlife or farmed stock.
5. An Improved understanding of the pathogen-induced diseases
of wild crustaceans, the role of industrial practices in expression
of these diseases and further, the interaction between wild and
farmed stocks (wild pathogens being the likely source of future
issues in culture) is required. The latter will be particularly
important in those regions where aquaculture expansion is
expected (e.g. Africa). These will all require the training of spe-
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cialists in crustacean disease diagnosis and control at the farm
level and the speciﬁc development of expertise at a national
level, particularly in those countries with signiﬁcant industries.
In other areas, a regional focus of expertise should be developed
to allow for rapid diagnosis, control and reporting of emergent
disease issues.
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